Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Inogen Inc, 3 years.
Inogen Inc
Director
Bioventus Inc.
Director
Novanta Inc.
Director
Kestra Medical Technologies Ltd.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Inogen Inc | Grant or award | +28,081 | — | — |
| Jun 2, 2026 | Bioventus Inc. | Option exercise | +32,282 | — | — |
| Jan 2, 2026 | Novanta Inc. | Option exercise | +1,325 | — | — |
| Sep 4, 2025 | Kestra Medical Technologies Ltd. | Grant or award | +10,909 | — | — |
| Jul 11, 2025 | Novanta Inc. | Option exercise | +572 | — | — |
| Jun 2, 2025 | Bioventus Inc. | Option exercise | +26,493 | — | — |
| May 14, 2025 | Inogen Inc | Grant or award | +30,612 | — | — |
| Jun 16, 2024 | Bioventus Inc. | Option exercise | +1,814 | — | — |
| Jun 7, 2024 | Bioventus Inc. | Option exercise | +30,400 | — | — |
| Jun 5, 2024 | Inogen Inc | Grant or award | +21,871 | — | — |
| Jun 16, 2023 | Bioventus Inc. | Option exercise | +1,813 | — | — |
| Jun 6, 2023 | Bioventus Inc. | Option exercise | +16,648 | — | — |
| May 31, 2023 | Inogen Inc | Grant or award | +17,094 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.